Public Company News
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, Results from a Phase 3 study of the Company's human epidermal growth factor rece...
2025-10-20 13:59
2010
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- October 20, 2025- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrou...
2025-10-20 13:21
1805
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025
SUZHOU, China, Oct. 20, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ovarian cancer (OC) and HER2-positive metastatic colore...
2025-10-20 13:15
2064
KLN Drives Libya's Wellhead Platform A Project Toward Completion, One of the Mediterranean Sea's Largest Offshore EPCI Projects to Bolster Energy Infrastructure
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK), through its division KLN Project, today announced significant progress on the Wellhead Platform A (WHPA) project inLibya's Bahr Essalam field. As consortium leader appointed by Mellitah Oil & Gas Co...
2025-10-20 12:29
1779
Nongshim Shin Ramyun Light Ups New York Times Square with 'KPop Demon Hunters'
- Global campaign celebrates the U.S. debut of the movie-inspired collaboration package - NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Nongshim carried out a global campaign at New York Times Square to celebrate the launch of Shin Ramyun in collaboration with Netflix's hit animated film 'KPop Demon H...
2025-10-20 11:23
1858
Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's trophoblast cell-s...
2025-10-20 10:36
2631
Agoda and Premier Inn Partner to Capture Rising Asian Traveler Interest in UK and Europe
The partnership aims to connect travelers from Asia and beyond to over 900 properties across the UK,Germany and Ireland SINGAPORE, Oct. 20, 2025 /PRNewswire/ -- Global digital travel platform Agoda has announced a new partnership with theUnited Kingdom's (UK) largest hotel chain Premier Inn maki...
2025-10-20 10:30
1917
Save Now, Travel through March: T'way Air Announces Fall Savings to Korea
Promo Code FLYOCT & Special Coupons for Travel through March 2026
TAIPEI, Oct. 20, 2025 /PRNewswire/ -- T'way Air, Korea's leading low-cost
carrier, invites travelers to enjoy special savings throughOctober 31 on
Taiwan-Korea bookings for travel untilMarch 28, 2026.
2025-10-20 09:00
3372
Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability
SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic ma...
2025-10-20 09:00
2681
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Once-Monthly Subcutaneous Depot Treatment Formulation of Small Molecule GLP-1R Agonist ASC30 for Obesity
- The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) ofsmall molecule GLP-1 receptor (GLP-1R) agonist ASC30 in 65 participants with obesity or overweight. - The ult...
2025-10-20 08:10
2671
Webull Reduces Minimum ASX Trading Fee To $1
* Webull Australia now offers the lowest-cost CHESS-sponsored brokerage fee minimums for trading ASX shares * The new pricing structure is paired with Webull's industry-leading technology and free live pricing data * $1.00 minimum fees will be made available to Australian clients from 20 Oc...
2025-10-20 06:00
3322
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held inBerlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblast cel...
2025-10-18 22:46
3243
Manulife Hong Kong and JUST FEEL Promote Emotional Well-Being with City's First "My Flag Day"
500 family volunteers distribute over 10,000 free flags to encourage the public to share their feelings HONG KONG, Oct. 18, 2025 /PRNewswire/ -- Manulife Hong Kong and JUST FEEL, a Hong Kong-based NGO dedicated to emotional education, successfully held the city's first-ever "My Flag Day" today. ...
2025-10-18 16:23
3995
Research Updates on a Phase III Clinical Trial of Anbenitamab (KN026) Presented at ESMO Congress 2025 LBA Oral Presentation Session
SUZHOU, China, Oct. 18, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholl...
2025-10-18 14:59
2866
Yunji Technology Debuts on HKEX, Partners with Luxshare Precision to Accelerate Global Expansion
HONG KONG, Oct. 18, 2025 /PRNewswire/ -- Beijing Yunji Technology Co., Ltd.
(the "Company"; Stock code: 2670) today announced that shares of the Company
have started to be traded on the Main Board of The Stock Exchange of Hong Kong
Limited under the stock code "2670".
2025-10-18 10:12
5046
Agoda Joins as Main Sponsor of Singapore's Iconic #HuntTheMouse Cash Hunt
SINGAPORE, Oct. 18, 2025 /PRNewswire/ -- Digital travel platform Agoda has signed up as a main sponsor for the much-anticipated #HuntTheMouse cash hunt in Singapore. Running from 16 October to 14 December 2025, the event is organized by Singaporean company Sqkii and offers participants a chance to...
2025-10-18 09:19
2818
NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension
NEW YORK, Oct. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Automakers await 5-ye...
2025-10-17 20:55
2757
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
CHENGDU, China, Oct. 17, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin (also known as A166) was approved for marketi...
2025-10-17 20:22
2575
Autoliv: Financial Report July - September 2025
STOCKHOLM, Oct. 17, 2025 /PRNewswire/ -- Q3 2025: Record 3rd quarter sales, operating income and EPS Financial highlights Q3 2025 $2,706 million net sales 5.9% net sales increase 3.9% organic sales growth* 9.9% operating margin 10.0% adjusted operating margin* $2.28 diluted EPS, 31% increase $2....
2025-10-17 20:10
2335
Minesto part of Swedish high-level delegation to South Korea
GOTHENBURG, Sweden, Oct. 17, 2025 /PRNewswire/ -- This week, leading ocean energy technology developer Minesto was part of a high-level Swedish delegation toSouth Korea aiming to explore new partnerships and strengthen bilateral collaboration in the green transition. The delegation, led by HRH Cr...
2025-10-17 20:05
1900
Week's Top Stories
Most Reposted
InfoComm Asia 2026 - Asia's Super Connector for Professional AV - Takes Place Next Week in Bangkok
[Picked up by 297 media titles]
2026-07-07 09:00
PropertyGuru Group's 2025 Sustainability Report Reinforces its Commitment to More Resilient and Inclusive Urban Futures Across Southeast Asia
[Picked up by 291 media titles]
2026-07-08 12:09
A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 291 media titles]
2026-07-10 13:30
NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 286 media titles]
2026-07-09 08:00Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
[Picked up by 285 media titles]
2026-07-07 06:00
Most Read
Founder Olive Tai Appointed Chairman of the Board of Synagistics; John Wu Appointed Chief Executive Officer as Company Enters Next Stage of AI and Digital Commerce Growth
2026-07-06 20:23
7320
Straits Forum | Taiwanese Youth Tells: Six Years Rooted in the Mainland - From Starting a Business to Ringing the Bell at HKEX
2026-07-04 16:29
6589
